MENU
Back to Top

Friday, 14 May 2021 - Program Schedule

*all sessions and times are listed in the Eastern Time Zone (EDT) and subject to change. To assist with how to convert times to your specific time zone; just click here.

08:00 - 09:00

Exhibit Hall Open Visit and meet with exhibitors

09:00 - 10:30

Coagulation and Thromboembolic Issues in Vascular Anomalies

    Moderators: Gulraiz Chaudry (United States), Cameron Trenor (United States)

09:00 - 09:25

Introductory Clinical Overview Shelley Crary (United States)

09:25 - 10:10
 

Case Presentations with Panel Discussion Panelists: Shelley Crary (United States), Ludovic Drouet (France), Ahmad Alomari (United States), Steven Fishman (United States)

 

09:25 - 09:40   Case 1: Thromboembolic risk in KTS/CLOVES Aparna Annam (United States)

 

09:40  - 09:55  Case 2: Severe Coagulopathy in Lympovenous Malformation Dario Teplisky (Argentina)

 

09:55 - 10:10   Case 3: Apixaban to Control Pain in Extensive Lower Limb Venous Malformation Matthew Jones (United Kingdom)

10:10 - 10:30

Innovations and Future Trends Ludovic Drouet (France)

10:30 - 10:35

Break

10:35 - 12:05

Complex AVMs are the Most Challenging Vascular Anomalies to Treat

    Moderators: Dov Goldenberg (Brazil), Ahmad Alomari (United States)

10:35 - 10:45

Brief Introduction to Types of Arteriovenous MalformationsGiacomo Coletti (Italy)

10:45 - 11:00

Clinical Case on Diagnosis and Treatment Planning Tony Penington (Australia)

11:00 - 11:15

Clinical Case Solved Exclusively by IR David Lord (United Kingdom)

11:15 - 11:30

Early Approach to AVM and Outcomes Xiaoxi Lin (China)

11:30 - 11:45

Clinical Case on Surgical Treatment Gresham Richter (United States)

11:45 - 12:00

Where are we in Pharmacologic Treatment (mTor, MEK inhibitors) Laurence Boon (Belgium)

12:00 - 12:05

Final Comments

12:10 - 13:00

Exhibit Hall Open Visit and meet with exhibitors

12:10 - 14:10
 

PROS Diagnosis and Treatment: Past, Present, and Future
An Interactive Cases-based Symposium Lymphatic Anomalies (CLA) from Bench to Bedside and Back!

 

non-CME Symposium supported by

12:10 - 12:15

Opening Remarks Nii Ankrah, MD

12:15 - 12:55

The Diagnostic Odyssey of PROSNii Ankrah, MD, Mary Lisha Paul, MD
 

Case 1: Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing

Case 2: Activating PIK3CA somatic mutation in congenital unilateral isolated muscle overgrowth of the upper extremity

12:55 - 13:00

Break

13:00 - 14:00

Then and Now: Moving Toward Targeted TherapeuticsNii Ankrah, MD, Mary Lisha Paul, MD
 

Cases 3 and 4: Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes

14:00 - 14:10

Questions & Answers